State Supported Brand Medications - Arkansas
State Supported Brand Medications
After a brand name drug’s patent has expired there may be a company producing a generic drug that meets the FDA’s criteria for the “181-day generic drug exclusivity”, which means it is protected from competition from other generic versions of the same drug product for approximately 181 days. After the expiration of the 181-day exclusivity period, other generic companies may be poised to enter the market and as more generic drugs are available, the price begins to fall.
The state Medicaid pharmacy program staff will monitor these high cost brand-name drugs and check the Federal rebate file to determine the most economical choice for the state, either:
- The brand name drug due to a higher Federal rebate and lower final net cost to the state -- or
- The generic drug that likely has the 181-day generic exclusivity without other generic competition
Return to Provider Documents